Biocon Limited announced the successful completion of its Qualified Institutions Placement (QIP) issue, allotting 11,26,64,585 equity shares of face value ₹5 each. The allotment was approved by the Fund Raising Committee at a meeting held on January 14, 2026. The issue price was fixed at ₹368.35 per equity share, including a premium of ₹363.35 per equity share.

The total amount raised through this QIP amounts to ₹41,500 million (₹4,150 crore). The Issue was open from January 12, 2026, to January 14, 2026.

Following the allotment, Biocon's paid-up equity share capital has increased to ₹8,10,45,38,865, comprising 1,62,09,07,773 equity shares. The company also informed that the trading window for dealing in its securities, which was closed for the QIP, will reopen on January 17, 2026.

The announcement also included a list of allottees who received more than 5% of the equity shares offered in the issue, with SBI Contra Fund and ICICI Prudential Value Fund being significant allottees.